Skip to content

Death by Triglycerides: A Multifaceted Case of Dyslipidemia, Obesity, and PMOS Resulting In Lethal Acute Pancreatitis.

Sep 2026 · American Journal of Forensic Medicine and Pathology · 0 citations · 21 references
Medicine

TL;DR

The combination of the patient's familial dyslipidemia, PMOS, and obesity created a compounding effect of metabolic dysfunction leading to her sudden death, highlighting the need for close follow-up in patients with these conditions and better education on the possible consequences of their interplay.

Abstract

A 23-year-old female was found unresponsive after 3 weeks of illness and presented to urgent care a day before her death with a complaint of nausea, vomiting, and abdominal cramping. She had a history of obesity and polyendocrine metabolic ovarian syndrome (PMOS). At autopsy, nonhemorrhagic acute pancreatitis and steatohepatitis were identified. During the exam, areas of fat congealing within pooled blood were noted. Tubes of blood drawn during the examination became grossly lipemic at room temperature. Toxicological and laboratory testing showed a triglyceride level of 5440 mg/dL, HDL 9 mg/dL, total cholesterol 740 mg/dL, 0.06% wt/vol acetone in peripheral blood, and therapeutic levels of fluconazole. Postmortem genetic testing revealed an LDLR mutation associated with familial hypercholesterolemia. Obesity, high cholesterol, and PMOS are all disturbances known to perpetuate further metabolic issues, including severe hypertriglyceridemia (HTG). Most causes of severe HTG are the result of multigenic or polygenic mutations and are further exacerbated by exposure to nongenetic secondary factors. The combination of the patient's familial dyslipidemia, PMOS, and obesity created a compounding effect of metabolic dysfunction leading to her sudden death. Overall, this case highlights the need for close follow-up in patients with these conditions and better education on the possible consequences of their interplay, which can prove lethal.

View source

Similar papers

Case report Open access Sep 2026

When biochemistry fails: extreme lipemia masking hypertriglyceridemia-induced acute pancreatitis treated with insulin

Abstract A 30-year-old previously healthy male presented to the emergency department with malaise, nausea, and abdominal pain. He was alert and oriented but in significant discomfort. Examination revealed abdominal guarding without peritoneal signs, and other systemic examinations were unremarkable. Initial laboratory...

Elif Unal Kaya, Mert Ali Kaya · 0 citations
Open access Sep 2026

Extreme hypertriglyceridemia revealing clinically suspected congenital generalized lipodystrophy in adulthood a diagnosic challenge

Lipodystrophy syndromes are rare disorders characterized by a deficiency of adipose tissue and associated severe metabolic complications. We report the case of a 41-year-old woman with long-standing diabetes diagnosed at the age of 16, following diabetic ketoacidosis and recurrent metabolic decompensations, and a prior...

S. Hassane, Z. Serhane, W. Moussaoui et al. · 0 citations
Open access Jan 2026

Diagnosis of Antipsychotic Medication‐Induced Severe Hypertriglyceridaemia by the Phenomenon of Pseudohyponatraemia and Successful Management With Variable‐Rate Intravenous Insulin Infusion: A Case Report

Background Hypertriglyceridaemia (HTG) is a common condition resulting from genetic and environmental factors. Second‐generation antipsychotic (SGA) medications are classically associated with the development of metabolic syndrome, of which HTG is a hallmark feature. Severe HTG is the third most common cause of acute p...

Adam Coleman, G. Kettyle, M. Monaghan et al. · 1 citation
Review Open access Oct 2026

Metreleptin improves glucose metabolism and hepatic steatosis in a patient with Werner syndrome and partial lipodystrophy: a case report with review of literature.

Werner syndrome (WS) is a rare autosomal recessive progeroid disorder caused by mutations in the WRN gene and is characterized by distinctive physical features and metabolic complications, including insulin resistance, diabetes, hypertriglyceridemia, and hepatic steatosis. Although lipodystrophy is a recognized compone...

Shogo Iwamura, Nagisa Nirei, Mari Matsuyama et al. · 0 citations
Review Open access 2026

Clinical significance and management of hypertriglyceridemia

It is concluded that secondary causes must be ruled out upon diagnosis and non-HDL cholesterol is highlighted as a critical secondary therapeutic target for comprehensive cardiovascular risk management.

L. Popović, Sandra Singh-Lukač, I. Rasulić et al. · 0 citations
Sep 2026

Cannabinoid Hyperemesis Syndrome in a Resource-Limited Setting: Clinical and Biochemical Insights from an Unusual Water-Triggered Presentation

Cannabinoid hyperemesis syndrome (CHS) is a paradoxical disorder of chronic, heavy cannabis use, defined by recurrent nausea and intractable vomiting that resolve after cannabis cessation. In settings where toxicological screening is unavailable, the diagnosis rests on a careful drug history, the pattern of illness, an...

H. Ibezim, I. O. Eboreime-Oikeh, A. O. Opajobi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.